We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Technology Accelerates Cell-Based ELISA Procedures While Reducing Error Risk

By LabMedica International staff writers
Posted on 07 Apr 2010
New technology allows laboratories to automate fully cell-based enzyme-linked immunosorbent assay (ELISA) procedures, thereby reducing the risk of human error, contamination, and time spent on tedious manual procedures.

The handling of cells in automated systems requires smooth and reliable operation and specialized equipment. More...
Agilent Automation Solutions (Santa Clara, CA, USA) designed the BioCel system to dispense cells into microplates and perform a series of alternating incubations and reagent additions. Automated control of intermediate plate batches, cell medium removal, and absorbance detection also formed part of the process.

The BioCel system is ideally suited to this complex assay format due to its powerful dynamic scheduling software, flexible liquid-handling options, and the ability to integrate simply third-party instruments. Integrating an Agilent vertical pipetting station, multiple labware stackers, plate washer, CO2 incubator, and microplate absorbance reader, the BioCel system is shown to provide unattended automation of approximately 500 plates per run in a three-day experiment. Using the described configuration, cells can be plated and stored at a rate of one minute per plate.

The Agilent BioCel system automates any microplate-based protocol providing maximum walk-away time and throughput, all in the most compact design. With modular cells, options for various enclosures, and environmental control, BioCel systems can be customized to the user's individual needs. Operated by Agilent VWorks software, a flexible and efficient scheduling software, BioCel systems deliver a very long walk-away time and throughput.

From stand-alone units to fully integrated systems, Agilent Automation Solutions teams key sample preparation and creative walk-away automation approaches with personalized customer service to provide complete solutions for the laboratory. Agilent designs and manufactures high-performance equipment for processes for pharmaceutical, biotech, and genomic research.

Related Links:

Agilent Automation Solutions




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Portable POCT Blood Gas Analyzer
BD100
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.